THE ASSOCIATION BETWEEN TUMOR NECROSIS FACTORαGENE POLYMORPHISM AND ASTHMA

被引:0
作者
高金明
林耀广
邱长春
刘怡雯
马毅
刘英
机构
[1] Department of Respiratory Disease
[2] PUMC Hospital
[3] CAMS &PUMC
[4] Beijing
[5] National Laboratory of Medical Molecular Biology
[6] Institute of Basic Medical Science
[7] CAMS & PUMC
关键词
tumor necrosis factor; asthma; genetic;
D O I
暂无
中图分类号
R562.25 [];
学科分类号
1002 ; 100201 ;
摘要
Objective.In this study,we investigated the hypothesis that tumor necrosis factor(TNF)α-308gene polymorphism might be of the genetic predisposition to asthma and asthma phenotypes.Methods.TNFα-308gene polymorphism was genotyped in221random unrelated Northern Chinese population(comprising125asthmatics and96healthy controls)and52individuals from12asthmatic families with Han ethnic by using polymerase chain reaction(PCR)-restriction fragment length polymor-phism(RFLP).Methacholine(Mch)broncho-challenge test,bronchial reversibility test and lung function were underwent in all asthmatics.Results.TNFα-3082homozygosity was present at a significantly higher frequency in asthmatics than that in controls(20.8%vs11.4%,P<0.05,OR2.259),the TNF allele2was also higher in asthmatics compared with controls(0.42vs0.33,P<0.01).TNFα-3082homozygosity was an weak independent risk factor for asthma etiology(OR0.226,P<0.05).Moreover,patients carrying TNFα-3082homozy-gosity had less responsive to inhaledβ 2 -agonist in20minutes than patients carrying other two genotypes(24.1%vs29.5%vs38.8%,P<0.05).Linkage analysis didn't support that TNFαgene was linked to asthma (Likelihood of odds,LOD<1)based on familial data.Conclusion These results suggest that TNFα-3082homozygosity may be of a component contribut-ing to the genetic predisposition to asthma ,and airway responsiveness toβ2 -agonist.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 10 条
[1]  
AlbuquerqueRV,HaydenCM,PalmerLJ,etal.Associa-tionofpolymorphismwithinthetumornecrosisfactor(TNF)genesandchildhoodasthma. ClinExpAllergy . 1998
[2]  
LouisR,LeyderE,MalaiseM,etal.Lackofassociationbetweenadultasthmaandthetumornecrosisfactorα-308polymorphismgene. European Respiratory Journal . 2000
[3]  
MoffattMF,JamesA,RyanG,etal.Extendedtumornecrosisfactor/HLA-DRhaplotypesandasthmainanAus-tralianpopulationsample. Thorax . 1999
[4]  
RenzettiLM,PaciorekPM,TannuSA,etal.Pharmacolog-icalevidencefortumornecrosisfactorasamediatorofal-lergicinflammationintheairways. Journal of Pharmacology and Experimental Therapeutics . 1996
[5]  
CooksonW.Theallianceofgenesandenvironmentalinasth-maandallergy. Nature . 1999
[6]  
WilsonAG,SymonsJA,McDowellTL,etal.Effectsofapolymorphisminthehumantumornecrosisfactorαpromo-torontranscriptionalactivation. Proceedings of the National Academy of Sciences of the United States of America . 1997
[7]  
MoffattMF,CooksonWOCM.Tumornecrosisfactorhaplo-typesandasthma. HumMolGenet . 1997
[8]  
AmericanThoracicSociety.Standardfordiagnosisandcareofpatientswithchronicobstructivepulmonarydisease(COPD)andasthma. AmRevRespirDis . 1987
[9]  
DrazenJM,YandavaCN,DubeL,etal.PharmacogeneticassociationbetweenALOX5promotorgenotypeandthere-sponsetoanti-asthmatreatment. Nature Genetics . 1999
[10]  
WinchesterEC,MillwoodIY,RaudL,etal.AssociationoftheTNF-α-308(G→A)polymorphismwithself-report-edhistoryofchildhoodasthma. Human Molecular Genetics . 2000